Shenzhen New Industries Biomedical 新产业
24 significant filings since 29 May 2026: 1 on detention or investigation, 3 on share pledge and 12 on equity incentive, and 2 other kinds. The latest, on 31 Aug 2026: 关于控股股东部分质押股份办理延期购回手续的公告.
自 29 May 2026 起有 24 份重大公告：detention or investigation 1 份、share pledge 3 份、equity incentive 12 份，另有 2 类。最新一份（31 Aug 2026）：关于控股股东部分质押股份办理延期购回手续的公告。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥48.73 · Low 最低 ¥47.52 · −2.43% on the previous close of ¥48.92The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 9 Sep 2024 | 国信证券 | 张佳博,张超 | Buy 买入 | ▼ | Outperform 增持 |
| 24 Aug 2020 | 申港证券 | 曹旭特,程佳 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 中邮证券 | 盛丽华 | Buy 买入 | 31 Aug 2026 | 1 | — |
| 国信证券 | 张超,陈曦炳,彭思宇 | Outperform 增持 | 28 Aug 2026 | 3 | — |
| 太平洋 | 谭紫媚 | Buy 买入 | 20 Aug 2026 | 3 | — |
| 西南证券 | 杜向阳,雷瑞 | Unrated | 16 Aug 2026 | 1 | — |
| 开源证券 | 余汝意,陈峻,石启正 | Buy 买入 | 14 Aug 2026 | 2 | — |
| 诚通证券 | 李志新 | Outperform 增持 | 29 Apr 2026 | 1 | — |
| 华安证券 | 谭国超,钱琨 | Outperform 增持 | 31 Oct 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 12 reports. 每行为该券商近十二个月的最新研报；12 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。